Page 3 - Genentech News Today

The latest vaccine technology is being used to create personalised treatments that target the DNA of patients specific tumours.

A man with bowel cancer has become the first person in England to be treated with a personalised jab for the disease on the NHS.

A man with bowel cancer has become the first of thousands to be treated with a personalised jab as part of the NHS Cancer Vaccine Launch Pad.

Clinicians look for specific mutations in a patient's tumour and create a personalised treatment designed to stimulate the immune system after surgery to remove tumours so it can recognise and attack any remaining cancer cells.

Although questions remain about ideal treatment strategies, consistent data have shown that patients should be treated early.

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional analyses of INAVO120 will be presented in an...

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional analyses of INAVO120 will be presented in an oral

Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options1,2Additional...

BioNTech and CEPI aim to enhance local R&D, clinical and commercial-scale manufacturing capacities to develop potential mRNA vaccines in Africa, for AfricaCEPI to fund up to $145 million to support BioNTech